trending Market Intelligence /marketintelligence/en/news-insights/trending/qRv6kjG0cya0lHNZc9xfng2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Cynata Therapeutics completes A$6M capital raising


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

Cynata Therapeutics completes A$6M capital raising

Cynata Therapeutics Ltd. completed a placement of about 9.23 million fully paid ordinary shares at 65 Australian cents apiece, for gross proceeds of A$6.0 million before costs.

The oversubscribed placement was made to both new and existing institutional investors, Cynata said. The placement is expected to occur on or about Jan. 27, and the shares to be issued Jan. 30.

Cynata plans to use proceeds along with its FUJIFILM Corp. investment to accelerate and expand the development of Cymerus, its therapeutic mesenchymal stem cell technology.

The placement was jointly managed by Shaw and Partners Ltd. and CPS Capital Group Pty Ltd.

As of Jan. 20, US$1 was equivalent to A$1.32.